A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Although combination antiretroviral therapy has resulted in a considerable improvement in the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the emergence of resistant virus is a significant obstacle to the effective management of HIV infection and AIDS. We have developed...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Petropoulos, Christos J., Parkin, Neil T., Limoli, Kay L., Lie, Yolanda S., Wrin, Terri, Huang, Wei, Tian, Huan, Smith, Douglas, Winslow, Genine A., Capon, Daniel J., Whitcomb, Jeannette M.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2000
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC89793/
https://ncbi.nlm.nih.gov/pubmed/10722492
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires